Publications in Scientific Journals:

D. Classen-Houben, D. Schuster, T. Da Cunha, A. Odermatt, G. Wolber, U. Jordis, B. Küenburg:
"Selective inhibition of 11beta -hydroxysteroid dehydrogenase 1 by 18alpha -glycyrrhetinic acid but not 18beta -glycyrrhetinic acid";
Journal of Steroid Biochemistry and Molecular Biology, 113 (2009), 248 - 252.

English abstract:
Elevated cortisol concentrations have been associated with metabolic diseases such as diabetes type 2
and obesity. 11 -hydroxysteroid dehydrogenase (11 -HSD) type 1, catalyzing the conversion of inactive
11-ketoglucocorticoids into their active 11 -hydroxy forms, plays an important role in the regulation
of cortisol levels within specific tissues. The selective inhibition of 11 -HSD1 is currently considered
as promising therapeutic strategy for the treatment of metabolic diseases. In recent years, natural
compound-derived drug design has gained considerable interest. 18 -glycyrrhetinic acid (GA), ametabolite
of the natural product glycyrrhizin, is not selective and inhibits both 11 -HSD1 and 11 -HSD2. Here,
we compare the biological activity of 18 -GA and its diastereomer 18 -GA against the two enzymes in
lysates of transfected HEK-293 cells and show that 18 -GA selectively inhibits 11 -HSD1 but not 11 -
HSD2. This is in contrast to 18 -GA, which preferentially inhibits 11 -HSD2. Using a pharmacophore
model based on the crystal structure of the GA-derivative carbenoxolone in complex with human 11 -
HSD1, we provide an explanation for the differences in the activities of 18 -GA and 18 -GA. This model
will be used to design novel selective derivatives of GA.
2009 Elsevier Ltd. All rights reserved.

glycyrrhetic acids stereochem oxidn stereochem oxidn glycyrrhetic acids

Created from the Publication Database of the Vienna University of Technology.